title: Does natalizumab therapy benefit patients with multiple sclerosis?
authors: Veterans Affairs Medical Center, Neurology Section, Medical Service Dallas, Veterans Affairs North Texas Health Care System, Dallas2Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas3Department of Neur.
authors: Olaf
authors: O
authors: Stüve
authors: Section on Research Methods and Clinical Trials, Department of Biostatistics, University of Alabama at Birmingham.
authors: Gary R
authors: GR
authors: Cutter
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab